Viewing StudyNCT00209261



Ignite Creation Date: 2024-05-05 @ 12:00 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00209261
Status: COMPLETED
Last Update Posted: 2011-05-19
First Post: 2005-09-13

Brief Title: A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis PNE
Sponsor: Ferring Pharmaceuticals
Organization: Ferring Pharmaceuticals

Organization Data

Organization: Ferring Pharmaceuticals
Class: INDUSTRY
Study ID: FE992026 CS022
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Ferring Pharmaceuticals
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Clinical Development Support
Old Organization: Ferring Pharmaceuticals

Collaborators